2013 CPT Coding Update! — Presentation Transcript    2013 CPTCODINGUPDATE! CPT® is a registeredtrademark of the AmericanMe...
A few CPT 2013 CPT codes.. Arthrodesis, pre-sacral interbody technique, including disc space preparation,discectomy, with ...
performed; humeral or ulnar component Revision of total elbow arthroplasty, including allograftwhen24371 performed; humera...
supervision and interpretation, includes angiography of the cervicocerebralarch, when performed Selectivecatheter placemen...
Upper gastrointestinal endoscopy including esophagus,43252 stomach, and either the duodenum and/orjejunum as appropriate; ...
PMP22 (peripheral myelin protein 22) (eg, Charcot-Marie-81325 Tooth, hereditary neuropathy with liabilityto pressure palsi...
metapneumovirus,87633 parainfluenza virus, respiratory syncytialvirus, rhinovirus), multiplex reversetranscription and amp...
Upcoming SlideShare
Loading in …5
×

2013 cpt coding update

774 views
695 views

Published on

0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total views
774
On SlideShare
0
From Embeds
0
Number of Embeds
0
Actions
Shares
0
Downloads
6
Comments
0
Likes
0
Embeds 0
No embeds

No notes for slide

2013 cpt coding update

  1. 1. 2013 CPT Coding Update! — Presentation Transcript 2013 CPTCODINGUPDATE! CPT® is a registeredtrademark of the AmericanMedical Association. CPT® 2013 code changes announced; new codes reflect care advancements Allowphysicians to report advancements in healthcare services Molecular Tests Care Coordination SINGLE LARGEST EXPANSION 186 New Codes Added 119 Outdated Codes Deleted 263 Another Revised Codes SINGLE LARGEST EXPANSION Result of: Significant advancements in medical understanding and testing for Molecular disease. Including Human Genome Project The 2013 codes include 116 for molecular pathology! New Codes Will Enhance: Reporting of innovative diagnostic tools Improve Health Outcomes Reduce Long-Term Care Cost Additional Updates Reflect Practice Changes and Improvements in Cardiology Neurologic Testing Psychiatry "Medical knowledge is constantlyadvancing, and as steward of CPT, theAMA invests extensive resources each yearto keep the code set current withcontemporary medical science andtechnology," AMA President Jeremy A.Lazarus, MD When is the code set updated? The code set is updated annually with direct input from the health care community: Practicing Physicians Allied Health Professionals Advisors from more than 100 medical specialty societies Such input has allowed the code set to better support the reporting needs of physicians and other professionals in emerging models of care, including patient-centered medical homes and accountable care organizations. "Tapping into the clinical expertise of the health care community produces the practical enhancements that CPT needs to reflect the coding demands of the modern health care system," Dr. Lazarus said.
  2. 2. A few CPT 2013 CPT codes.. Arthrodesis, pre-sacral interbody technique, including disc space preparation,discectomy, with posterior instrumentation, with image guidance, includes bone graft, when performed,lumbar, L4-L5 interspace (List separately in addition to code for primary0309T procedure Motor functionmapping using non-invasive navigated transcranial magnetic stimulation(nTMS) for therapeutic treatmentplanning,0310T upper and lower extremity Non-invasive calculation and analysis of central arterialpressure0311T waveforms with interpretation and report Vagus nerve blocking therapy (morbid obesity);laparoscopic implantation of neurostimulator electrode array, anterior and posterior vagal trunks adjacent toesophagogastric junction(EGJ),0312T with implantation of pulse generator, includes programming Vagusnerve blocking therapy (morbid obesity); laparoscopic revision or replacement of vagaltrunkneurostimulator electrode0313T array, including connection to existing pulse generatorVagus nerve blocking therapy (morbid obesity); laparoscopic removal of vagal trunkneurostimulatorelectrode array and pulse0314T generator Vagus nerve blocking therapy (morbid obesity); removal of pulsegenerator agus nerve blocking therapy (morbid obesity); removal of0315T pulse generator Vagus nerveblocking therapy (morbid obesity); replacement of0316T pulse generator Vagus nerve blocking therapy(morbid obesity); neurostimulator pulse generator electronic analysis, includes reprogramming whenperformed0317T Implantation of catheter-delivered prosthetic aortic heart valve,0318T open thoracicapproach, (eg,transapical, other than transaortic)Implantation of catheter-delivered prosthetic aortic heart valve,0319T open thoracic approach,(eg,transapical, other than transaortic0320T Insertion of subcutaneous defibrillator electrode Insertion ofsubcutaneous implantable defibrillator pulse generator0321T only with existing subcutaneous electrodeRemoval of subcutaneous implantable defibrillator pulse generator0322T only Removal of subcutaneousimplantable defibrillator pulse generator with replacement of subcutaneous implantable defibrillatorpulse0323T generator only0324T Removal of subcutaneous defibrillator electrode Repositioning of subcutaneous implantabledefibrillator electrode0325T and/or pulse generator Electrophysiologic evaluation of subcutaneousimplantable defibrillator (includes defibrillation threshold evaluation, induction of arrhythmia, evaluation ofsensing for arrhythmia termination, and programming or reprogramming of sensing or therapeutic0326Tparameters Interrogation device evaluation (in person) with analysis, review and report, includesconnection, recording and disconnection per patient encounter; implantable subcutaneous leaddefibrillator0327T system Programming device evaluation (in person) with iterative adjustment of theimplantable deviceto test the function of the device and select optimal permanent programmed values0328Twithanalysis; implantable subcutaneous lead defibrillator system0580F Multidisciplinary care plan developed or updated (DSP) Patient transferred directly fromanesthetizing location to critical care0581F unit (Peri2) Patient not transferred directly from anesthetizinglocation to critical0582F care unit (Peri2)0583F Transfer of care checklist used (Peri2)0584F Transfer ofcare checklist not used (Peri2)Did we say a few? Symptoms and signs of distal symmetric polyneuropathy reviewed1500F anddocumented (DSP) 1501F Not initial evaluation for condition (DSP Patient queried about pain and paininterference with function1502F using a valid and reliable instrument (DSP1503F Patient queried aboutsymptoms of respiratory insufficiency (DSP)1504F Patient has respiratory insufficiency (DSPArthrodesis, pre-sacral interbody technique, including disc space preparation, discectomy, with posteriorinstrumentation, with image22586 guidance, includes bone graft when performed, L5-S1 interspaceRevision of total shoulder arthroplasty, including allograft when23473 performed; humeral orglenoidcomponent Revision of total shoulder arthroplasty, including allograft when23474 performed;humeral andglenoid component Revision of total elbow arthroplasty, including allograft when24370
  3. 3. performed; humeral or ulnar component Revision of total elbow arthroplasty, including allograftwhen24371 performed; humeral and ulnar componentBronchoscopy, rigid or flexible, including fluoroscopic guidance, when performed; with balloonocclusion,when performed, assessment of air leak, airway sizing, and31647 insertion of bronchial valve(s), initial lobeBronchoscopy, rigid or flexible, including fluoroscopic guidance, when performed; with removal ofbronchial31648 valve(s), initial lobe Bronchoscopy, rigid or flexible, including fluoroscopic guidance, whenperformed; with removal of bronchial valve(s), each additional lobe (List separately in addition to31649code for primary procedure) Bronchoscopy, rigid or flexible, including fluoroscopic guidance, whenperformed; with balloon occlusion, when performed, assessment of air leak, airway sizing, and insertion ofbronchial valve(s), each additional lobe (List31651 separately in addition to code for primary procedure[s]Bronchoscopy, rigid or flexible, including fluoroscopic guidance, when performed; withbronchialthermoplasty, 131660 lobeBronchoscopy, rigid or flexible, including fluoroscopic31661 guidance, when performed; withbronchialthermoplasty, 2 or more lobes Thoracentesis, needle or catheter, aspiration of32554 the pleuralspace; without imaging guidance Thoracentesis, needle or catheter, aspiration of32555 the pleural space;with imaging guidance Pleural drainage, percutaneous, with insertion of32556 indwelling catheter; withoutimaging guidance Pleural drainage, percutaneous, with insertion of32557 indwelling catheter; with imagingguidanceThoracic target(s) delineation for stereotactic body32701 radiation therapy (SRS/SBRT), (photon or particlebeam), entire course of treatment Transcatheter aortic valve replacement (TAVR/TAVI) with33361prosthetic valve; percutaneous femoral artery approach Transcatheter aortic valve replacement(TAVR/TAVI) with33362 prosthetic valve; open femoral artery approach Transcatheter aortic valvereplacement (TAVR/TAVI) with33363 prosthetic valve; open axillary artery approach Transcatheter aorticvalve replacement (TAVR/TAVI) with33364 prosthetic valve; open iliac artery approachTranscatheter aortic valve replacement (TAVR/TAVI) with33365 prosthetic valve; transaorticapproach(e.g., median sternotomy, mediastinotomy) Transcatheter aortic valve replacement (TAVR/TAVI) withprosthetic valve; cardiopulmonarybypass support with33367 percutaneous peripheral arterial and venouscannulation (e.g., femoral vessels) (List separately in addition to code for primary procedure) Transcatheteraortic valve replacement (TAVR/TAVI) with prosthetic valve; cardiopulmonarybypass support with33368open peripheral arterial and venous cannulation (e.g., femoral, iliac, axillary vessels) (List separately inaddition to code for primary procedure) Transcatheter aortic valve replacement (TAVR/TAVI) withprosthetic valve; cardiopulmonary bypass support with33369 central arterial and venous cannulation (e.g.,aorta, right atrium, pulmonary artery) (List separately in addition to code for primary procedure) Insertion ofventricular assist device, percutaneous33990 including radiological supervision and interpretation; arterialaccess only Insertion of ventricular assist device, percutaneous33991 including radiological supervisionandinterpretation; both arterial and venous access, with transseptal punctureRemoval of percutaneous ventricular assist device at33992 separate and distinct session frominsertionRepositioning of percutaneous ventricular assist device33993 with imaging guidance at separate and distinctsession from insertion Non-selective catheter placement, thoracic aorta, with angiography of theextracranialcarotid, vertebral, and/or intracranial vessels, unilateral or bilateral, and all36221 associatedradiological supervision and interpretation, includes angiography of the cervicocerebral arch, whenperformed Selective catheter placement, common carotid or innominate artery, unilateral, any approach,with angiography of the ipsilateralextracranial carotid36222 circulation and all associated radiological
  4. 4. supervision and interpretation, includes angiography of the cervicocerebralarch, when performed Selectivecatheter placement, common carotid or innominate artery, unilateral, any approach, with angiography of theipsilateral intracranial carotid36223 circulation and all associated radiological supervision andinterpretation, includes angiography of the extracranialcarotid andcervicocerebral arch, when performedSelective catheter placement, internal carotid artery, unilateral, with angiography of theipsilateralintracranial carotid circulation and all associated radiological36224 supervision and interpretation, includesangiography of the extracranial carotid and cervicocerebralarch, when performed Selective catheterplacement, subclavian or innominate artery, unilateral, with angiography of the ipsilateral36225 vertebralcirculation and all associated radiological supervision and interpretation, includes angiography of thecervicocerebral arch, when performed Selective catheter placement, vertebral artery, unilateral, withangiography of the ipsilateralvertebral circulation and36226 all associated radiological supervision andinterpretation, includes angiography of the cervicocerebral arch, when performed Selective catheterplacement, external carotid artery, unilateral, with angiography of theipsilateral external carotid36227circulation and all associated radiological supervision andinterpretation (List separately in addition to codefor primary procedure) Selective catheter placement, each intracranial branch of the internal carotid orvertebral arteries, unilateral, with angiography of the selected vessel circulation and all36228 associatedradiological supervision and interpretation (e.g., middle cerebral artery, posterior inferior cerebellar artery)(List separately in addition to code for primary procedure)Transcatheter retrieval, percutaneous, of intravascular foreign body (e.g., fractured venous or arterialcatheter),37197 includes radiological supervision and interpretation, and imaging guidance(ultrasound orfluoroscopy), when performed Transcatheter therapy, arterial infusion for thrombolysis37211 other thancoronary, any method, including radiological supervision and interpretation, initial treatment dayTranscatheter therapy, venous infusion for thrombolysis, any37212 method, including radiologicalsupervision and interpretation, initial treatment day Transcatheter therapy, arterial or venous infusion forthrombolysis other than coronary, any method, including radiological supervision and interpretation,continued37213 treatment on subsequent day during course of thrombolytic therapy, including follow-upcatheter contrast injection, position change, or exchange, when performed; Transcatheter therapy, arterial orvenous infusion for thrombolysis other than coronary, any method, including radiological supervision andinterpretation, continued treatment on subsequent day during course of thrombolytic37214 therapy,including follow-up catheter contrast injection, position change, or exchange, when performed; cessation ofthrombolysis including removal of catheter and vessel closure by any methodElectro diagnostic studies for distal symmetric polyneuropathy not conducted (or3752Frequested),documented, or reviewed within 6 months of initial evaluation for condition (DSP) Patient hasclear clinical symptoms and signs that are highly suggestive of neuropathy ANDcannot be3753F attributedto another condition, AND has an obvious cause for the neuropathy(DSP) Screening tests for diabetesmellitus reviewed, requested,3754F or ordered (DSP) Cognitive and behavioral impairment screening3755Fperformed (DSP) Patient has pseudobulbar affect, sialorrhea, or3756F ALS related symptoms (DSP) Patientdoes not have pseudobulbar affect, sialorrhea, or3757F ALS related symptoms (DSP) Patient referred forpulmonary function testing or peak3758F cough expiratory flow (DSP)Take effect January 1, 2013.. Patient screened for dysphagia, weight loss, and3759F impaired nutrition, andresults documented(DSP) Patient exhibits dysphagia, weight loss, or impaired3760F nutrition (DSP) Patientdoes not exhibit dysphagia, weight loss, or3761F impaired nutrition (DSP)3762F Patient is dysarthric(DSP)3763F Patient is not dysarthric (DSP)38243 Hematopoietic progenitor cell (HPC); HPC boostEsophagoscopy, rigid or flexible; with optical43206 endomicroscopy
  5. 5. Upper gastrointestinal endoscopy including esophagus,43252 stomach, and either the duodenum and/orjejunum as appropriate; with optical endomicroscopy Preparation of fecal microbiota for instillation,44705including assessment of donor specimen4540F Disease modifying pharmacotherapy discussed (DSP)Patient offered treatment for pseudobulbar affect,4541F sialorrhea, or ALS related symptoms (DSP) Optionsfor noninvasive respiratory support discussed with4550F patient (DSP)4551F Nutritional support offered(DSP) Patient offered referral to a speech language pathologist4552F (DSP)Patient offered assistance in planning for end of life issues4553F (DSP)4554F Patient received inhalationalanesthetic agent (Peri2) Patient did not receive inhalational anesthetic4555F agent (Peri2) Patient exhibits 3or more risk factors for post-operative4556F nausea and vomiting (Peri2) Patient does not exhibit 3 or morerisk factors for post-4557F operative nausea and vomiting (Peri2) Patient received at least 2 prophylacticpharmacologic4558F anti-emetic agents of different classes preoperatively and intraoperatively (Peri2) Atleast 1 body temperature measurement equal to or greater than 35.5 degrees Celsius (or 95.9 degrees4559FFahrenheit) recorded within the 30 minutes immediately before or the 15minutes immediately afteranesthesia end time (Peri2)Anesthesia technique did not involve general or neuraxial4560F anesthesia (Peri2)4561F Patient has acoronary artery stent (Peri2)4562F Patient does not have a coronary artery stent (Peri2) Patient receivedaspirin within 24 hours prior to anesthesia4563F start time (Peri2) Cystourethroscopy, with injection(s) forchemodenervation52287 of the bladder Chemodenervation of muscle(s); muscle(s) innervated by64615facial, trigeminal, cervical spinaland accessory nerves, bilateral (eg, for chronic migraine) Thyroid uptake,single or multiple quantitative78012 measurement(s) (including stimulation, suppression, or discharge,when performed)Thyroid imaging (including vascular flow, when78013 performed); Thyroid imaging (including vascularflow, when performed); with single or multiple uptake(s)quantitative78014 measurement(s) (includingstimulation, suppression, or c discharge, when performed) Parathyroid planar imaging (includingsubtraction, when78071 performed); with tomographic(SPECT) Parathyroid planar imaging (includingsubtraction, when performed); with tomographic(SPECT), and concurrently78072 acquired computedtomography (CT) for anatomical localization DMD (dystrophin) (e.g., Duchenne/Becker muscular81161dystrophy) deletion analysis, andduplication analysis, if performed APC (adenomatous polyposis coli) (e.g.,familial81201 adenomatosis polyposis [FAP], attenuatedFAP) gene analysis; full gene sequenceAPC (adenomatous polyposis coli) (e.g., familial81202 adenomatosis polyposis [FAP], attenuatedFAP)gene analysis; known familial variants APC (adenomatous polyposis coli) (e.g., familial81203 adenomatosispolyposis [FAP], attenuatedFAP) gene analysis; duplication/deletion variants EGFR (epidermal growthfactor receptor) (e.g., non- small cell lung cancer) gene analysis, common variants81235 (e.g., exon 19LREA deletion, L858R, T790M, G719A, G719S, L861Q) GJB2 (gap junction protein, beta 2, 26kDa;connexin 26)81252 (e.g., nonsyndromic hearing loss)gene analysis; full gene sequence GJB2 (gap junctionprotein, beta 2, 26kDa; connexin 26)81253 (eg, nonsyndromic hearing loss)gene analysis; known familialvariantsGJB6 (gap junction protein, beta 6, 30kDa, connexin 30) (e.g., nonsyndromic hearing loss)gene analysis,common81254 variants (e.g., 309kb [del(GJB6-D13S1830)] and 232kb [del(GJB6-D13S1854)]) PTEN(phosphatase and tensin homolog) (eg,81321 Cowden syndrome, PTEN hamartoma tumor syndrome) geneanalysis; full sequence analysis PTEN (phosphatase and tensin homolog) (eg,81322 Cowden syndrome,PTEN hamartoma tumor syndrome) gene analysis; known familial variant PTEN (phosphatase and tensinhomolog) (eg,81323 Cowden syndrome, PTEN hamartoma tumor syndrome) gene analysis;duplication/deletion variant PMP22 (peripheral myelin protein 22) (e.g., Charcot-Marie-81324 Tooth,hereditary neuropathy withliability to pressure palsies) gene analysis; duplication/deletion analysis
  6. 6. PMP22 (peripheral myelin protein 22) (eg, Charcot-Marie-81325 Tooth, hereditary neuropathy with liabilityto pressure palsies) gene analysis; full sequence analysis PMP22 (peripheral myelin protein 22) (e.g.,Charcot-Marie-81326 Tooth, hereditary neuropathy with liability to pressure palsies) gene analysis; knownfamilial variant81479 Unlisted molecular pathology procedure Oncology (ovarian), biochemical assays oftwo proteins81500 (CA-125 and HE4), utilizing serum, with menopausal status, algorithm reported as a riskscore Oncology (ovarian), biochemical assays of five proteins (CA-125, apolipoprotein A1, beta-2microglobulin,81503 transferrin and pre-albumin), utilizing serum, algorithm reported as a risk scoreEndocrinology (type 2 diabetes), biochemical assays of seven analytes (glucose, HbA1c,insulin, hs-CRP,81506 adiponectin, ferritin, interleukin 2-receptor alpha), utilizing serum or plasma, algorithmreporting a risk scoreFetal congenital abnormalities, biochemical assays of two81508 proteins (PAPP-A, hCG [any form]),utilizing maternal serum, algorithm reported as a risk score Fetal congenital abnormalities, biochemicalassays of81509 three proteins (PAPP-A, hCG [any form], DIA), utilizing maternal serum, algorithmreported as a risk score Fetal congenital abnormalities, biochemical assays of81510 three analytes (AFP,uE3, hCG [any form]), utilizing maternal serum, algorithm reported as a risk score Fetal congenitalabnormalities, biochemical assays of four analytes (AFP, uE3, hCG [any form], DIA) utilizingmaternal81511 serum, algorithm reported as a risk score (may include additional results from previousbiochemical testing) Fetal congenital abnormalities, biochemical assays of five analytes (AFP, uE3, totalhCG,hyperglycosylated hCG,81512 DIA) utilizing maternal serum, algorithm reported as a risk score81599Unlisted multianalyte assay with algorithmic analysis82777 Galectin-3 Cell enumeration using immunologic selection and86152 identification in fluid specimen(e.g. ,circulating tumor cells in blood); Cell enumeration using immunologic selection and86153identification in fluid specimen (e.g. ,circulating tumor cells in blood); physician interpretation and report,when required86711 Antibody; JC (John Cunningham) virus Antibody to human leukocyte antigens (HLA),solid phase assays (e.g., microspheres or beads, ELISA, flow cytometry);86828 qualitative assessment ofthe presence or absence of antibody(ies) to HLA Class I and Class II HLA antigens Antibody to humanleukocyte antigens (HLA), solid phase assays (e.g., microspheres or beads, ELISA, Flow cytometry);86829qualitative assessment of the presence or absence of antibody(ies) to HLA Class I or Class II HLA antigensAntibody to human leukocyte antigens (HLA), solid phase assays (e.g., microspheres or beads, ELISA,Flow cytometry);86830 antibody identification by qualitative panel using completeHLA phenotypes, HLAClass I Antibody to human leukocyte antigens (HLA), solid phase assays (e.g., microspheres or beads,ELISA, Flow cytometry);86831 antibody identification by qualitative panel using completeHLAphenotypes, HLA Class II Antibody to human leukocyte antigens (HLA), solid phase assays (e.g.,microspheres or beads, ELISA, Flow cytometry);86832 high definition qualitative panel for identification ofantibodyspecificities (e.g., individual antigen per bead methodology), HLA Class I Antibody to humanleukocyte antigens (HLA), solid phase assays (e.g., microspheres or beads, ELISA, Flow cytometry);86833high definition qualitative panel for identification of antibodyspecificities (e.g., individual antigen per beadmethodology), HLA Class II Antibody to human leukocyte antigens (HLA), solid phase86834 assays (e.g.,microspheres or beads, ELISA, Flow cytometry); semi-quantitative panel (e.g., titer), HLA Class IAntibody to human leukocyte antigens (HLA), solid phase assays (eg,86835 microspheres or beads, ELISA,Flow cytometry); semi-quantitative panel (e.g., titer), HLA Class II Infectious agent detection by nucleicacid (DNA or RNA); respiratory virus (e.g., adenovirus, influenza virus, coronavirus,metapneumovirus,87631 parainfluenza virus, respiratory syncytialvirus, rhinovirus), multiplex reversetranscription and amplified probe technique, multipletypes or subtypes, 3-5 targets Infectious agentdetection by nucleic acid (DNA or RNA); respiratory virus (e.g., adenovirus, influenza virus, coronavirus,metapneumovirus,87632 parainfluenza virus, respiratory syncytialvirus, rhinovirus), multiplex reversetranscription and amplified probe technique, multipletypes or subtypes, 6-11 targets Infectious agentdetection by nucleic acid (DNA or RNA); respiratory virus (e.g., adenovirus, influenza virus, coronavirus,
  7. 7. metapneumovirus,87633 parainfluenza virus, respiratory syncytialvirus, rhinovirus), multiplex reversetranscription and amplified probe technique, multipletypes or subtypes, 12-25 targets Infectious agentgenotype analysis by nucleic acid (DNA or RNA);87910 cytomegalovirus Infectious agent genotypeanalysis by nucleic acid (DNA or RNA);87912 Hepatitis B virusOptical endomicroscopic image(s), interpretation and report, real-88375 time or referred, eachendoscopicsession Influenza vaccine, inactivated, subunit, adjuvanted, for90653 intramuscular use90672 Influenzavirus vaccine, quadrivalent, live, for intranasal use Influenza virus vaccine, quadrivalent, split virus,preservative90685 free, when administered tochildren 6-35 months of age, for intramuscular use Influenzavirus vaccine, quadrivalent, split virus, preservative90686 free, when administered toindividuals 3 years ofage and older, for intramuscular use Influenza virus vaccine, quadrivalent, split virus, when administeredto90687 children 6-35 monthsof age, for intramuscular use Influenza virus vaccine, quadrivalent, split virus,when administered to90688 individuals 3 years of age and older, for intramuscular use Hepatitis B vaccine,adult dosage (2 dose schedule), for90739 intramuscular useInteractive complexity (List separately in addition to the90785 code for primary procedure)90791Psychiatric diagnostic evaluation90792 Psychiatric diagnostic evaluation with medical servicesPsychotherapy, 30 minutes with patient and/or family90832 member Psychotherapy, 30 minutes withpatient and/or family member when performed with an evaluation and90833 management service (Listseparately in addition to the code for primary procedure) Psychotherapy, 45 minutes with patient and/orfamily90834 member Psychotherapy, 45 minutes with patient and/or family member when performed withan evaluation and90836 management service (List separately in addition to the code for primary procedure)Psychotherapy, 60 minutes with patient and/or family90837 member Psychotherapy, 60 minutes withpatient and/or family member when performed with an evaluation and90838 management service (Listseparately in addition to the code for primary procedure)90839 Psychotherapy for crisis; first 60 minutesPsychotherapy for crisis; each additional 30 minutes (List90840 separately in addition to code for primaryservice) Pharmacologic management, including prescription and review of medication, when performedwith psychotherapy90863 services (List separately in addition to the code for primary procedure)Gastrointestinal transit and pressure measurement, stomach91112 through colon, wireless capsule, withinterpretation and report Percutaneous transluminal coronary angioplasty; single92920 major coronaryartery or branchGet more educational information on the next slide! Percutaneous transluminal coronary angioplasty;each92921 additional branch of a major coronary artery (List separately in addition to code for primaryprocedure) Percutaneous transluminal coronary atherectomy, with92924 coronary angioplasty whenperformed; single major coronary artery or branch Percutaneous transluminal coronary atherectomy,with92925 coronary angioplasty when performed; each additional branch of a major coronary artery (Listseparately in addition to code for primary procedure)

×